Your browser doesn't support javascript.
loading
Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy.
Scheele, Wim; Diamond, Susan; Gale, Jeremy; Clerin, Valerie; Tamimi, Nihad; Le, Vu; Walley, Rosalind; Grover-Páez, Fernando; Perros-Huguet, Christelle; Rolph, Timothy; El Nahas, Meguid.
Afiliação
  • Scheele W; Pfizer Inc., Cambridge, Massachusetts; wim.scheele@pfizer.com.
  • Diamond S; San Antonio Kidney Disease Center, San Antonio, Texas.
  • Gale J; Pfizer Inc., Cambridge, Massachusetts.
  • Clerin V; Pfizer Inc., Cambridge, Massachusetts.
  • Tamimi N; Pfizer Ltd., Sandwich, United Kingdom.
  • Le V; Pfizer Inc., Cambridge, Massachusetts.
  • Walley R; Pfizer Ltd., Sandwich, United Kingdom.
  • Grover-Páez F; Institute of Experimental and Clinical Therapeutics, Universidad de Guadalajara, Guadalajara, México; and.
  • Perros-Huguet C; Pfizer Inc., Cambridge, Massachusetts.
  • Rolph T; Pfizer Inc., Cambridge, Massachusetts.
  • El Nahas M; Sheffield Kidney Institute, Sheffield, United Kingdom.
J Am Soc Nephrol ; 27(11): 3459-3468, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27113485

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Nefropatias Diabéticas / Albuminúria / Inibidores da Fosfodiesterase 5 / Compostos Heterocíclicos com 2 Anéis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Soc Nephrol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Nefropatias Diabéticas / Albuminúria / Inibidores da Fosfodiesterase 5 / Compostos Heterocíclicos com 2 Anéis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Soc Nephrol Ano de publicação: 2016 Tipo de documento: Article